Notably, the GBM lines most sensitive to MEK inhibition all exhibited loss of NF1 expression, while lines with intact NF1 displayed a lesser, but a variable degree of growth inhibition (Figure 3A and B). This evidence concerns the gene MAP2K7 and glioblastoma.